Concepedia

Author

Charlotte Domblides

Université de BordeauxORCID

Also Known As

C. Domblides, Charlotte Domblides, Domblides, Charlotte, Victor De Ledinghen

101

Publications

1.5K

Citations

18

H-Index

29

Concepts

All Affiliations

Université de BordeauxInsermCentre National de la Recherche ScientifiqueBordeaux Population HealthImmunology from Concept and Experiments to Translation
CD

About

Charlotte Domblides is an author at Université de Bordeaux specializing in medicine, tumor biology, and cell signaling.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

359

2

Cell Biology

2

2

183

3

Immunology

2

2

188

4

Natural Sciences

1

1

128

5

Cellular Physiology

1

1

128

Charlotte Domblides

×

12

Publications

550

Citations

11

H-Index

YearCitations

Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma

Charlotte Domblides, Karen Leroy, I. Monnet,

Journal of Thoracic Oncology

2020

133

Secretion of protein disulphide isomerase AGR2 confers tumorigenic properties

Delphine Fessart, Charlotte Domblides, Tony Avril,

eLife

2016

128

Baseline co-medications may alter the anti-tumoural effect of checkpoint inhibitors as well as the risk of immune-related adverse events

Marie Kostine, Eleonora Mauric, Alice Tison,

European Journal of Cancer

2021

87

Human γδ T cell sensing of AMPK-dependent metabolic tumor reprogramming through TCR recognition of EphA2

Christelle Harly, Stephen Paul Joyce, Charlotte Domblides,

Science Immunology

2021

55

Clinical impact of STK11 mutation in advanced-stage non-small cell lung cancer

Pietro Rosellini, Samuel Amintas, Charline Caumont,

European Journal of Cancer

2022

43

Nonsmall cell lung cancer from HIV-infected patients expressed programmed cell death-ligand 1 with marked inflammatory infiltrates

Charlotte Domblides, Martine Antoine, Cécile Hamard,

AIDS

2017

25

Effect of prior immunotherapy on the efficacy of chemotherapy in advanced non‐small cell lung cancer: A retrospective study

Luc Héraudet, Tara Delon, Rémi Veillon,

Thoracic Cancer

2022

18

Real-world efficacy of the dabrafenib-trametinib (D-T) combination in BRAF V600E-mutated metastatic non-small cell lung cancer (NSCLC): Results from the IFCT-2004 BLaDE cohort

Aurélie Swalduz, Michèle Beau‐Faller, David Planchard,

Lung Cancer

2024

15

Prognostic Role of Inflammasome Components in Human Colorectal Cancer

Charlotte Domblides, Isabelle Soubeyran, Lydia Lartigue,

Cancers

2020

14

Central venous catheter-related bloodstream infections: Epidemiology and risk factors for hematogenous complications

Elisabeth Carolle Ngo Bell, Virginie Chapon, Emilie Bessède,

Infectious Diseases Now

2024

11

Page 1